Conjunctival IgD, LL-37, and pentraxin levels and their relationship with visual electrophysiological responses in the development of diabetic retinopathy

dc.authorscopusidKadriye Yağmur Oruç / 58187315000
dc.authorwosidKadriye Yağmur Oruç / AAR-9552-2020
dc.contributor.authorOruç, Aykut
dc.contributor.authorTekkaya, Emre
dc.contributor.authorOruç, Kadriye Yağmur
dc.contributor.authorSeymen, Hakkı Oktay
dc.date.accessioned2025-04-17T07:43:01Z
dc.date.available2025-04-17T07:43:01Z
dc.date.issued2025
dc.departmentİstinye Üniversitesi, Rektörlük, Temel Bilimler Bölümü
dc.description.abstractConjunctival IgD, LL-37, and pentraxin levels and their relationship with visual electrophysiological responses in the development of diabetic retinopathy
dc.identifier.citationÇalış, G. Ü. N. E. R., Sönmez, A. T. A. Ç., Akkaya, E., Demirtaş, H., & Dalkıran, B. (2025). Attenuation of Neuropathic Pain by P2X7 Receptor Antagonist Brilliant Blue G. ACTA PHYSIOLOGICA, 241(S733).
dc.identifier.endpage52
dc.identifier.issn1748-1708
dc.identifier.issn1748-1716
dc.identifier.startpage51
dc.identifier.urihttps://hdl.handle.net/20.500.12713/6131
dc.identifier.volume241
dc.identifier.wosWOS:001430730700087
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.institutionauthorOruç, Kadriye Yağmur
dc.institutionauthoridKadriye Yağmur Oruç / 0000-0002-3747-5136
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofActa physiologica
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectDiabetic Retinopathy
dc.subjectIgD
dc.subjectLL-37
dc.subjectPTX3
dc.subjectElectroretinography
dc.titleConjunctival IgD, LL-37, and pentraxin levels and their relationship with visual electrophysiological responses in the development of diabetic retinopathy
dc.typeOther

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: